Surgical Innovations Group plc
SUN.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | -£0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 6.5% | -6.6% | -3% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 31.3% | 24.3% | 32.9% | 22.7% |
| EBITDA | £0 | -£0 | -£0 | £0 |
| % Margin | 6.1% | -19.8% | -1.9% | 1.5% |
| Net Income | £0 | -£0 | -£0 | -£0 |
| % Margin | 0.3% | -25.2% | -7.9% | -2.1% |
| EPS Diluted | 0 | -0.002 | -0.001 | -0 |
| % Growth | 100% | -220% | -400% | – |
| Operating Cash Flow | -£0 | £0 | -£0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | £0 | -£0 | £0 |